Fulgent Genetics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1,278.00
9,576.00
18,276.00
18,730.00
21,351
Cost of Goods Sold (COGS) incl. D&A
936.00
5,069.00
6,722.00
8,551.00
10,697
Gross Income
342.00
4,507.00
11,554.00
10,179.00
10,654
SG&A Expense
1,332.00
9,519.00
10,636.00
13,661.00
15,724
EBIT
990.00
5,012.00
918.00
3,482.00
5,070
Unusual Expense
-
-
5,472.00
-
-
Non Operating Income/Expense
-
27.00
86.00
24.00
144
Pretax Income
990.00
4,985.00
4,468.00
3,001.00
4,636
Income Tax
-
-
920.00
1,015.00
36
Equity in Affiliates
-
-
-
524.00
935
Consolidated Net Income
990.00
4,985.00
5,388.00
2,510.00
5,607
Net Income
990.00
4,985.00
5,388.00
2,510.00
5,607
Net Income After Extraordinaries
2,303.00
1,656.00
5,429.00
2,510.00
5,607
Net Income Available to Common
4,283.00
8,314.00
13,666.00
2,510.00
5,607
EPS (Basic)
0.24
0.47
1.00
0.14
0.31
Basic Shares Outstanding
17,676.30
17,676.30
13,710.00
17,739.00
17,978
EPS (Diluted)
0.24
0.47
1.00
0.14
0.31
Diluted Shares Outstanding
17,676.30
17,676.30
13,710.00
17,739.00
17,978
EBITDA
794.00
4,437.00
2,088.00
1,754.00
2,907
Non-Operating Interest Income
-
-
-
457.00
578
Preferred Dividends
-
-
8,319.00
-
-
About Fulgent Genetics
View Profile
